Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the Quarter ended December 31, 2020.

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SWATI PODDARDesignation :- Company Secretary and Compliance Officer

We hereby submitting the Revised Un-Audited Financial Results for the half year ended September 30, 2020. 1. Un-Audited Financial Results for the half year ended as on September 30, 2020. 2. Un-Audited Statement of Assets and Liabilities for the half year ended as on September 30, 2020. 3. Cash Flow Statement for the half year ended as on September 30, 2020. 4. Limited Review Report for the half year ended as on September 30, 2020.

We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2020. 1. Un-audited Financial Results for the half year ended on 30th September, 2020. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2020. 3. Cash Flow Statement for the half year ended on 30th September, 2020. 4. Limited Review Report for the half year ended 30th September, 2020.

Outcome Of Board Meeting

Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve Dr Lalchandani Labs Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve -Unaudited Financial Results of the Company for the half year ended 30th September 2020 along with Limited Review report. -Any other Business matter, with the permission of the Chair.

Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30th September, 2020.

Dr Lalchandani Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here

Compliance Certificate For The Period Ended 30th September, 2020.

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the Quarter ended September 30, 2020.